Centessa Pharmaceuticals Plc Stock Price on November 25, 2024
| CNTA Stock | USD 17.53 0.37 2.16% |
If you're considering investing in Centessa Stock, it is important to understand the factors that can impact its price. As of today, the current price of Centessa Pharmaceuticals stands at 17.53, as last reported on the 24th of December, with the highest price reaching 18.00 and the lowest price hitting 16.50 during the day. Centessa Pharmaceuticals appears to be somewhat reliable, given 3 months investment horizon. Centessa Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0785, which signifies that the company had a 0.0785% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Centessa Pharmaceuticals PLC, which you can use to evaluate the volatility of the firm. Please makes use of Centessa Pharmaceuticals' Mean Deviation of 2.6, downside deviation of 3.79, and Risk Adjusted Performance of 0.0406 to double-check if our risk estimates are consistent with your expectations.
At present, Centessa Pharmaceuticals' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 397.6 M, whereas Total Stockholder Equity is forecasted to decline to about 232.1 M. . At present, Centessa Pharmaceuticals' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.17, whereas Price To Sales Ratio is forecasted to decline to 89.37. Centessa Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Centessa |
Sharpe Ratio = 0.0785
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CNTA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.45 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.27 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Centessa Pharmaceuticals is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Centessa Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 4.538 | Enterprise Value Ebitda 1.1183 | Price Sales 330.1416 | Shares Float 78.5 M | Wall Street Target Price 28.5714 |
Centessa Pharmaceuticals Main Headline on 25th of November 2024
Centessa Pharmaceuticals plc CEO Sells 928,950.00 in Stock by thelincolnianonline.com
Centessa Pharmaceuticals plc CEO Saurabh Saha sold 55,000 shares of Centessa Pharmaceuticals stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of 16.89, for a total transaction of 928,950.00. Following the sale, the chief executive officer now directly owns 575,661 shares of the
Centessa Pharmaceuticals Valuation on November 25, 2024
It is possible to determine the worth of Centessa Pharmaceuticals on a given historical date. On November 25, 2024 Centessa was worth 17.39 at the beginning of the trading date compared to the closed value of 17.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Centessa Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Centessa Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Centessa Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Centessa Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 18.28 | 18.33 | 16.95 | 17.04 | 1,110,171 | |
11/25/2024 | 17.39 | 18.23 | 16.82 | 17.10 | 956,314 |
| 17.00 | 17.45 | 16.43 | 17.30 | 559,268 |
| Backtest Centessa Pharmaceuticals | | | Centessa Pharmaceuticals History | | | Centessa Pharmaceuticals Valuation | Previous | Next |
Centessa Pharmaceuticals Trading Date Momentum on November 25, 2024
| On November 26 2024 Centessa Pharmaceuticals PLC was traded for 17.30 at the closing time. The top price for the day was 17.45 and the lowest listed price was 16.43 . The trading volume for the day was 559.3 K. The trading history from November 26, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 1.17% . The overall trading delta against the current closing price is 0.35% . |
Centessa Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Centessa Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Centessa Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Centessa financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Centessa Pharmaceuticals Stock history
Centessa Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Centessa is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Centessa Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Centessa Pharmaceuticals stock prices may prove useful in developing a viable investing in Centessa Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 96.2 M | 108.4 M | |
| Net Loss | -194.6 M | -204.3 M |
Centessa Pharmaceuticals Quarterly Net Working Capital |
|
Centessa Pharmaceuticals Stock Technical Analysis
Centessa Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Centessa Pharmaceuticals Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
Centessa Pharmaceuticals PLC cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Centessa Pharmaceuticals December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Centessa Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Centessa Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Centessa Pharmaceuticals stock market strength indicators, traders can identify Centessa Pharmaceuticals PLC entry and exit signals to maximize returns
Centessa Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Centessa Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Centessa Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Centessa to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0406 | |||
| Jensen Alpha | 0.1124 | |||
| Total Risk Alpha | 0.0323 | |||
| Sortino Ratio | 0.0291 | |||
| Treynor Ratio | 0.1467 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Centessa Stock analysis
When running Centessa Pharmaceuticals' price analysis, check to measure Centessa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Centessa Pharmaceuticals is operating at the current time. Most of Centessa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Centessa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Centessa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Centessa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |